Neudle.com: multiple sclerosis environmental factors

Differential
(Click to cross reference)

acetylcholine receptor

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

activities of daily living

activities of daily living scale

advances in neurology

adverse drug reaction

alemtuzumab

algorithm

alternative medicine

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, Parkinson-dementia-complex

analgesic

anemia

angiography, cerebral

angiography, spinal

anosmia

anterior horn cell disease

anti JC virus antibodies

antibodies to measles

anticoagulant, contraindications

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants, effectiveness

anticonvulsants, selection of

antiviral agents

apraxia

area postrema

area postrema syndrome

arrhythmia, cardiac

arteriovenous malformation, cerebral

atlanto axial dislocation, congenital

autonomic dysfunction

bacterial infection, CNS

Barkhof MR criteria for MS

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavior modification

biologic markers

blacks

bladder dysfunction

blood dyscrasias, neurologic findings with

bone marrow biopsy

bone scanning

bone survey

Borrelia burgdorferi infection

Call-Fleming syndrome

campylobacter infection

cancer, cerebrovascular accident complicating patients with

cannabinoids

carcinoma

cardiovascular disease

CAT scan, abnormal

cavernous sinus, syndrome

central nervous system, infection of

cerebellar atrophy, secondary

cerebellar degeneration

cerebral infarction, hemorrhagic

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, culture of

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, proteincytologic dissociation

cerebrovascular accident

cerebrovascular accident, arterial occlusion, location

cerebrovascular accident, incidence of

cerebrovascular accident, neonatal

cerebrovascular accident, prevention of

cerebrovascular accident, recurrent

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, women

cerebrovascular accident, work up for

cerebrovascular disease

cerebrovascular disease, risk factors in

channelopathy

chemotherapy, CNS treatment and complications with

child abuse

children

chiropractic manipulation

concentration, impaired

confusion

congenital heart disease, CNS complications with

controversies in neurology

corpus callosum, lesion of

cranial neuropathy, multiple

creatine phosphokinase(CPK)elevated

critical care unit

critical illness

cryptococcal meningitis

cytomegalovirus infection

deep gray nuclei

dehydration

delay in diagnosis

delayed muscle relaxation

delirium

delivery, complicated

dementia

demyelinating disease

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

disseminated intravascular coagulation(DIC)

dizziness

drug abuse

drug holiday

drug induced neurologic disorders

dural arteriovenous malformation

dural sinus thrombosis

dyskinesia

efficacy

electrical injury of nervous system

electroencephalogram, abnormalities of

electroencephalogram, brain mapping

electroencephalogram, periodic complexes

electromyogram

emergencies, neurologic

employment

encephalitis

encephalitis, autoimmune

encephalitis, bornavirus

encephalitis, human immunodeficiency virus type 1

encephalitis, viral

encephalocele

encephalopathy

encephalopathy, metabolic

endemic area

epidemiology of neurology

evidence-based research

exercise

extinction on double simultaneous stimulation

eye movement, painful

fibrinolytic agents, complications

fingolimod

fistula, arterio-venous, dural

fistula, arterio-venous, dural, spinal

gammaglobulin therapy, intravenous

gender

gene

gene mutation

genetic neurologic disorders

gray matter

Guillain Barre syndrome

Guillain Barre syndrome, complications

Guillain Barre syndrome, differential diagnosis of

Guillain Barre syndrome, etiology of

Guillain Barre syndrome, prognosis of

head injury

head injury, management of

head injury, mild

head injury, pediatric

head injury, prognosis in

headache

headache, children

headache, post traumatic

headache, recurrent

headache, severe

headache, thunderclap

heparin, low-molecular-weight

hepatitis B vaccine

heralding manifestation

herniated disc

herniated disc, lumbar

herniated disc, lumbar-conservative vs.surgical treat.of

herniated disc, lumbar-laminectomy

herpes simplex virus

herpes virus

herpes virus infection

herpes zoster

hiccoughs

highly active antiretroviral therapy

Hispanics

HLA

hormone replacement

hospital length of stay

hot bath test

human immunodeficiency virus type 1

human T-lymphotropic virus type I(HTLV-I)

hypertrophic intracranial pachymeningitis

hypotension, systemic

hypothalamus, lesion of

iatrogenic neurologic disorders

imbalance

imbalance, postural

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunization, neurologic complications with

immunocompetent

immunofluorescence

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

incidence

inclusion bodies

inclusion bodies, eosinophilic intranuclear

incontinence, fecal

infantile tremor syndrome

infection

infectious mononucleosis

infliximab

intellectual deficit

intellectual deterioration

interferon beta 1-a

intestinal biopsy

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracranial hemorrhage

Jakob-Creutzfeldt disease

leg weakness, bilateral

levamisole

life expectancy

limbic encephalitis

lipoprotein receptor-related protein 4

low back pain

lumbar spine manipulation

Lyme disease

lymphoma

lymphoma involving CNS

malformation, CNS, congenital

malformation, vascular

malformation, vascular, cerebral

malignancy screen

malpractice

marihuana

medical-legal aspects of neurology

medication withdrawal

medulla oblongata

medulla oblongata, lesion of

memory, impairment of

mental status, abnormal

mesial temporal sclerosis

middle cerebellar peduncle

middle cerebellar peduncle, lesion

migraine

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mimics

misdiagnosis

molecular genetics

monoclonal antibodies

monoclonal gammopathy

mononeuropathy

mononeuropathy multiplex

monoparesis

mortality

motor neuron disease

motor neuron disease, juvenile form

movement disorder

movement disorder, psychogenic

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, demyelinating disease

MRI, diffusion weighted

MRI, early changes in CVA

MRI, false negative

MRI, field strength, high

MRI, flow void, blood

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, incidental finding

MRI, spinal cord, increased intramedullary cord signal

MRI, T1 weighted high signal foci

multiple sclerosis, aggressive

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, clinical patterns

multiple sclerosis, cluster

multiple sclerosis, conjugal

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, epidemiology of

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, lesion location

multiple sclerosis, linoleic acid in

multiple sclerosis, monosymptomatic

multiple sclerosis, pathogenesis

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, etiology of

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myelitis

myelitis, longitudinal

myelitis, transverse

myelitis, transverse, prognosis

myelopathy

myelopathy, ascending

myelopathy, transverse

myopathy, critically ill

myotonia

nabiximols

natalizumab

natalizumab, discontinuation

nausea and vomiting

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-children

nerve conduction studies

neuroendocrinology

neurologic complications of, systemic cancer

neurologic disease

neurologic disease, diagnoses of

neurologic examination

neurologic signs

neurologic symptoms

neurologic testing

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuropathology

neuropathology, brain

neuropathy

neuropathy, painful

neuropathy, sensory

neuroprotective agents

nonsteroidal anti-inflammatory drug

occupational neurologic disorders

old age, neurology of

ophthalmoplegia

ophthalmoplegia, painful

opportunistic infection

opportunistic infection, CNS

optic chiasm

optic chiasm, lesion of

optic nerve, lesion of

optic neuritis

optic neuritis, bilateral

optic neuritis, children

optic neuritis, etiology of

optic neuritis, recurrent

optic neuritis, treatment of

optic neuropathy

oral contraceptives

oral contraceptives, neurologic complications with

organomegaly

orthostatic hypotension

pachymeningitis, cranial

paramyotonia congenita

patient information and support

percussion induced muscle contraction

periaqueductal lesion

perineum, numbness of

periodic paralysis

periodic paralysis, thyrotoxic

pernicious anemia

Persistent postural-perceptual dizziness

personality change

pertussis immunization

plasmapheresis

pleocytosis of cerebrospinal fluid

pneumonia

POEMS syndrome

polymerase chain reaction

polyneuropathy, critically ill

post concussive syndrome

post infectious polyneuropathy

posterior fossa, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

premarin

prenatal

prethrombotic state

prevention of neurologic disorders

primary intracranial hypotension

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

proprioception, abnormal

psychological testing

psychomotor retardation

pyramidal tract dysfunction

rapidly fatal neurologic illness

rapidly progressing neurologic illness

recurrent

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

renal failure

respiratory tract infection

retinal hemorrhages

retinal lesion

retrovirus

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

review article

rheumatoid arthritis

rheumatoid arthritis, neurologic complications of

risk factors

risk stratification

risk-benefit assessment

seizure, drug resistance

seizure, febrile

seizure, focal

seizure, immunization causing

seizure, intractable

seizure, intractable, treatment of

seizure, medication failure

seizure, neonatal

seizure, surgical treatment of

seizure, treatment of

seizure, treatment of, polytherapy

seizure, treatment, adjunctive therapy

selective serotonin reuptake inhibitors

sensory loss

sensory loss, cutaneous

septicemia

serologic testing

serologic testing, false negative

seronegative

seropositive

serotonin agonist

serotonin norepinephrine reuptake inhibitors

sinusitis

skin, lesions in neurologic disorders

sodium channel dysfunction

spasticity

spasticity, treatment of

spina bifida

spinal cord, lesion of

spinal cord, vascular malformation of

spinal manipulation

spirochete infection

status epilepticus

status epilepticus, nonconvulsive

steroid

steroid therapy, CNS treatment and complications with

stimulation, deep brain

stress, emotional

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

subdural hematoma

subdural hematoma, neonates and infants

suicide

sun exposure

superior sagittal sinus thrombosis

syphilis, diagnosis and treatment

systemic illness

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamus, lesion of-bilateral

tick-borne encephalitis

tissue plasminogen activator, intravenous

Tolosa Hunt syndrome

toxoplasma gondii

toxoplasmosis, acquired

toxoplasmosis, CNS

transient ischemic attack

transient neurologic deficit

trauma

travel, foreign

treatment of neurologic disorder

tremor

trigeminovascular system

triptans

tumor necrosis factor

tumor necrosis factor inhibitor

urinary tract infection

vaccination, neurologic complications with

vaccine

vagus nerve stimulation

varicella zoster virus

vascular malformation, children, intracranial

vasoconstrictive drugs

vasospasm

vasospasm, cerebral

vibratory sensation, abnormal

viral infection

viral infection, CNS

vision, blurred

vision, failure of in childhood

visual field defect

visual loss

visuospatial disturbance

vitamin D

vitamin deficiency

vitamin supplementation

vomiting, intractable

water channel antibodies

weakness

weakness, fatiguable

weakness, generalized

weight loss

wheelchair

white matter disease

white matter disease, periventricular

work loss

yellow fever

zinc

Showing articles 1750 to 1800 of 6888 << Previous Next >>

Vagal Nerve Stimulation Effect on Cerebellar Tremor in Multiple Sclerosis
Neurol 65:499, Marrosu,F.,et al, 2005

Polyneuropathy Associated with Interferon Beta Treatment in Patients with Multiple Sclerosis
Neurol 65:456-458, Ekstein,D.,et al, 2005

Risk of Hemorrhagic Stroke With Aspirin Use
Stroke 36:1801-1807, Gorelick,P.B. &Weisman,S.M., 2005

Attention-deficit Hyperactivity Disorder
Lancet 366:237-248, Biederman,J. &Faraone,S., 2005

Epileptic Seizures During Follow-up of Patients Treated for Primary Brain Tumors
Neurol 65:213-215, Hildebrand,J.,et al, 2005

Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005

Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
NEJM 353:375-381, Langer-Gould,A.,et al, 2005

Prothrombin 20210A and Oral Contraceptive Use as Risk Factors for Cerebral Venous Thrombosis
Cerebrovasc Dis 19:49-52, Gadelha,T.,et al, 2005

Cerebral Venous Thrombosis: Influence of Risk Factors and Imaging Findings on Prognosis
Clin Neurol Neurosurg 107:371-378, Appenzeller,S.,et al, 2005

Isolated Monoparesis Following Stroke
JNNP 76:805-807, Paciaroni,M.,et al, 2005

Chagas Disease Is an Independent Risk Factor for Stroke
Stroke 36:2015-2017, Oliveira-Filho,J.,et al, 2005

Major Risk Factors for Intracerebral Hemorrhage in the Young Are Modifiable
Stroke 36:1881-1885, Feldmann,E.,et al, 2005

Pregnancy Outcomes During Treatment with Interferon Beta-1a in Patients with Multiple Sclerosis
Neurol 65:802-806, Sandberg-Wollheim,M.,et al, 2005

Randomized, Controlled Trial of Cannabis-Based Medicine in Central Pain in Multiple Sclerosis
Neurol 65:812-819,788, Rog,D.J.,et al, 2005

Identification, Prognosis, and Management of Patients with Carotid Artery Near Occlusion
AJNR 26:2086-2094, Fox,A.J.,et al, 2005

Effect of Mitoxantrone on MRI in Progressive MS, Results of the MIMS Trial
Neurol 65:690-695, Krapf,H.,et al, 2005

Effect of Stress Related to the 9/11/2001 Terror Attack on Seizures in Patients with Epilepsy
Neurol 64:1815-1816, Klein,P. &van Passel,L., 2005

Enhanced Benefit of Increasing Interferon Beta-1a Dose and Frequency in Relapsing Multiple Sclerosis
Arch Neurol 62:785-792, Schwid,S.R.,et al, 2005

Internuclear Ophthalmoplegia
Arch Neurol 62:714-717, Keane,J.R., 2005

Nonarteritic Ischemic Optic Neuropathy Developing Soon After Use of Sildenafil (Viagra): A Report of Seven New Cases
J Neuroophthalmol 25:9-13, Pomeranz,H. &Bhavsar,A.R., 2005

Transcranial Low-Frequency Ultrasound-Mediated Thrombolysis in Brain Ischemia
Stroke 36:1441-1446, Daffertshofer,M.,et al, 2005

Folate, Vitamin B12, and Risk of Ischemic and Hemorrhagic Stroke
Stroke 36:1426-1431, Guelpen,B.V.,et al, 2005

Relation Between the Metabolic Syndrome and Ischemic Stroke or Transient Ischemic Attack
Stroke 36:1366-1371, Koren-Morag,N.,et al, 2005

Components of the Metabolic Syndrome and Risk for First-Ever Acute Ischemic Nonembolic Stroke in Elderly Subjects
Stroke 36:1372-1376, Milionis,H.J.,et al, 2005

Intracranial Bleeding in Patients with Vertebrobasilar Dolichoectasia
Stroke 36:1421-1425, Passero,S.G.,et al, 2005

A Systematic Review of the Risk Factors for Cervical Artery Dissection
Stroke 36:1575-1580, Rubinstein,S.M.,et al, 2005

Influenza Vaccination is Associated with a Reduced Risk of Stroke
Stroke 36:1501-1506, Grau,A.J.,et al, 2005

A 10-Item Smell Identification Scale Related to Risk for Alzheimers Disease
Ann Neurol 58:155-160, Taberr,M.H.,et al, 2005

A Simple Score (ABCD) to Identify Individuals at High Early Risk of Stroke After Transient Ischaemic Attack
Lancet 366:29-36, Rothwell,P.M.,et al, 2005

Blood Pressure Control and Risk of Stroke
Stroke 36:725-730, Li,C.,et al, 2005

Maternal and Infant Characteristics Associated with Perinatal Arterial Stroke in the Infant
JAMA 293:723-729, Lee,J.,et al, 2005

Role of Cerebral Amyloid Angiopathy in Intracerebral Hemorrhage in Hypertensive Patients
Neurol 64:1233-1237, Ritter,M.A.,et al, 2005

Cellular Telephones and Risk for Brain Tumors
Neurol 64:1189-1195, Christensen,H.C.,et al, 2005

Modafinil for Fatigue in MS
Neurol 64:1139-1143, Stankoff,B.,et al, 2005

Adding Aspirin to Clopidogrel After TIA and Ischemic Stroke
Neurol 64:1117-1121, Hankey,G.J. &Eikelboom,J.W., 2005

Gadolinium Encephalopathy in a Patient with Renal Failure
Neurol 64:1276-1278, Maramattom,B.V.,et al, 2005

Anti-a4 Integrin Therapy for Multiple Sclerosis
Neurol 64:1336-1342, Rice,G.P.A.,et al, 2005

Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005

Body Fat Distribution and Long-Term Risk of Stroke Mortality
Stroke 36:1021-1025, Tanne,D.,et al, 2005

Physical Methods for Preventing Deep Vein Thrombosis in Stroke
Stroke 36:1102-1103, Grandi,F.C.,et al, 2005

FDA Public Health advisory-Suspended Marketing of Tysabri (natalizumab)
www.fda.gov/cder/drug/advisory/natalizumab.htm.,(Feb 28), US Food and Drug Admin., 2005

Clinical and Imaging Predictors of Intracerebral Haemorrhage in Stroke Patients Treated with Intravenous Tissue Plasminogen Activator
JNNP 76:70-75, Derex,I.,et al, 2005

Prognostic Significance of Admission Levels of Troponin I in Patients With Acute Ischaemic Stroke
JNNP 76:76-81, Di Angelantonio,E.,et al, 2005

Phenytoin Exposure Is Associated With Functional and Cognitive Disability After Subarachnoid Hemorrhage
Stroke 36:583-587, Naidech,A., et al, 2005

Timing of TIAs Preceding Stroke
Neurol 64:817-820, Rothwell, P.M. & Warlow, C.P., 2005

Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005

Atypical Antipsychotic Drugs and Risk of Ischaemic Stroke: Population Based Retrospective Cohort Study
BMJ 330:445-448, Gill,S.S., et al, 2005

Lamotrigine and the Risk of Malformations in Pregnancy
Neurol 64:955-960, 938, Cunnington, M. , et al, 2005

A Fatal Encephalitis
Lancet 365:358, Schankin, C.J., et al, 2005

Risk of Ischaemic Stroke in People With Migraine: Systemic Review and Meta-analysis of Observational Studies
BMJ 330:63-65, 54, Etminan,M.,et al, 2005

Showing articles 1750 to 1800 of 6888 << Previous Next >>